ALCAMENA STEM CELL THERAPEUTICS, LLC
Last verified 2026-05-16. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.5Mattributed |
|---|---|
| Latest round | grant, $1.5M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | halethorpe, md, usa |
| Industry | biotech |
| Stage | unknown |
| Website | alcamenabio.com |
Alcamena develops Supernatural Peptides via its PepGenesis platform to target previously undruggable proteins. It serves pharma and biotech partners pursuing therapeutics in metabolic, neurological, and oncology disease. Differentiator: GenAI-guided directed evolution for peptide engineering.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $1.5M | undisclosed |
Detected tech stack
Nginx, WordPress 7.0, Bricks, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.5M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.5M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | alcamenabio.com, read 2026-05-16 |
| Description | self-reported | alcamenabio.com, read 2026-05-16 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.